Chicago IL 克罗恩病临床试验
9项针对 克罗恩病的研究正在 Chicago及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
招募中3 期
- University of Chicago Medical Center ( Site 5066), Chicago
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
招募中2 期
- University of Chicago Medical Center /ID# 267400, Chicago
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
招募中3 期
- Rush University Medical Center, Chicago
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
招募中3 期
- Rush University Medical Center-Site Number: 8400015, Chicago
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
招募中2 期
- Rush University Medical Center, Chicago
A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
招募中2 期
- Rush University Medical Center, Chicago
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
招募中4 期
- University of Chicago Medicine, Chicago
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
招募中
- University of Chicago Medicine, Chicago
Treatment of Moderate to Severe Refractory Crohn's Disease
招募中1/2 期
- Northwestern, Chicago
- University of Chicago, Chicago
其他城市的 克罗恩病试验
- New York City, NY35 项研究
- Cleveland, OH19 项研究
- St. Louis, MO19 项研究
- Boston, MA19 项研究
- Miami, FL19 项研究
- Orlando, FL17 项研究
- Houston, TX17 项研究
- Atlanta, GA17 项研究
- Tyler, TX16 项研究
- San Diego, CA15 项研究
- San Antonio, TX15 项研究
- Los Angeles, CA15 项研究
Chicago的其他研究
- 非小细胞肺癌61 项研究
- 乳腺癌58 项研究
- 癌症（所有类型）51 项研究
- 转移性癌症45 项研究
- 前列腺癌45 项研究
- 肥胖症41 项研究
- 肺癌41 项研究
- 卵巢癌36 项研究
- 卒中34 项研究
- 结直肠癌33 项研究
- 心力衰竭31 项研究
- 超重28 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月5日。每项研究自行设定入选标准，由研究团队决定谁能参与。